The story of Sildenafil presents a nuanced case for observers in the pharmaceutical sector. While initially a tremendous success, producing billions, the intellectual property expiration and the subsequent flood of https://adult579232.iyublog.com/40504409/the-little-copyright-and-the-pharmaceutical-industry-a-speculative-play